All In Biotech

Free tool

FAERS Monitor: Claritin-D 24 Hour

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020470 or its brand name (Claritin-D 24 Hour, Loratadine, Pseudoephedrine Sulfate). Reports on generic versions are filed under their own applications.

Reports

6,977

Serious

1,257

18% of reports

Hospitalization

497

Death reported

72

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,537
  • insomnia677
  • drug effect decreased395
  • product use issue381
  • dizziness324
  • somnolence259
  • headache252
  • nausea231
  • fatigue219
  • dyspnoea203
  • feeling abnormal193
  • palpitations186
  • off label use178
  • dry mouth176
  • anxiety158

Reports by year received

View as table
YearReports
2004114
2005114
200695
200784
200881
2009107
2010106
2011127
2012325
2013417
20141,591
2015702
2016738
2017601
2018330
2019307
2020244
202181
2022206
2023301
2024109
2025121
202676

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,182 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug effect decreasedSignal39522.320.27,962
insomniaSignal6777.77.13,967
dry mouthSignal1766.65.7824
product use issueSignal3816.15.61,639
palpitationsSignal1864.84.2557
somnolenceSignal2593.93.4556
drug ineffectiveSignal1,5373.53.42,950
feeling abnormalSignal1932.42.1163
dizziness3242.01.8155
anxiety1581.71.443
headache2521.21.19
dyspnoea2031.10.91
nausea2310.90.84
fatigue2190.80.76
off label use1780.60.545

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.